FreeObituary David Alberts, founding member of the University of Arizona Cancer Center, dies at 83 September 15, 2023Vol.49 No.34By Lisa M. Dahm and Mark Anthony Febbo
FreeIn the Archives In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch September 15, 2023Vol.49 No.34By Deborah Doroshow and Alexandria Carolan
Conversation with The Cancer LetterFree Shelley Earp steps down at UNC Lineberger, ending a 22-year directorshipA search for his replacement begins September 08, 2023Vol.49 No.33By Paul Goldberg
White House Just one cancer drug—ibrutinib—figures on the CMS list of 10 drugs subject to price negotiations under Medicare Part DPhRMA sues to block the program September 08, 2023Vol.49 No.33By Matthew Bin Han Ong
Conversation with The Cancer Letter Crystal Denlinger named the first woman to lead NCCN September 08, 2023Vol.49 No.33By Paul Goldberg
Guest Editorial What’s the right dose of sotorasib? Is it 240 mg qd or 4x that?The Oct. 5 ODAC will be a nailbiter September 08, 2023Vol.49 No.33By Mark J. Ratain
NCI Moonshot and HHS agencies to develop standards for data interoperability September 08, 2023Vol.49 No.33By Matthew Bin Han Ong
Free More than 500 bills restricting trans medical care threaten LGBTQ+ people with cancer August 11, 2023Vol.49 No.32By Alexandria Carolan
Cancer History ProjectConversation with The Cancer LetterFree John Laszlo’s dual role: (1) Working to cure childhood leukemia, and (2) Writing the authoritative book on itHis father, Daniel Laszlo, did early work on folate antagonists August 11, 2023Vol.49 No.32By Alexandria Carolan and Paul Goldberg
